AB-161 - CAS 2848560-66-5

AB-161 is an orally active destabilizer of HBV RNA and an inhibitor of PAPD5/7, primarily targeting the liver. It treats hepatitis B virus (HBV) infection by reducing hepatitis B surface antigen (HBsAg) levels, exhibiting an EC50 value of 2.2 nM for HBsAg. AB-161 is applicable in HBV infection research.

HBV

Microbiology/Virology

2848489

C21H21F2N3O5

433.41

C(C)(C)(C)[C@@H]1CC2=C(C3=C1C=C(C(O)=O)C(=O)N3)N=C4N2C=C(OC)C=C4OC(F)F

-20°C

Ice Packs

Small Compound